Risk factors for end-stage renal disease - 25-year follow-up

Archives of Internal Medicine

Volumn 169, Issue 4, 2009, Pages 342-350

  Hsu, Chi Yuan ^a   Iribarren, Carlos ^b,c   McCulloch, Charles E ^b   Darbinian, Jeanne ^c   Go, Alan S ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; URIC ACID;

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; CONFIDENCE INTERVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; EDUCATION; ETHNICITY; FAMILY HISTORY; FEMALE; FOLLOW UP; HAZARD RATIO; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; NOCTURIA; OBESITY; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RACE; RISK FACTOR; SELF REPORT; SEX; TIME SERIES ANALYSIS; URIC ACID BLOOD LEVEL;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; CONFIDENCE INTERVALS; CREATININE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NOCTURIA; ODDS RATIO; OVERWEIGHT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEINURIA; RESEARCH DESIGN; RISK FACTORS; UNITED STATES; URIC ACID;

EID: 61449162241     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2008.605     Document Type: Article

References (39)

1. Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015 [published correction appears in J Am Soc Nephrol. 2006;17(2):591]. J Am Soc Nephrol. 2005;16 (12):3736-3741.
2. Rosenberg ME, Hsu CY. Chronic kidney disease and progression. NephSAP. 2004;3(6):304-308.
3. Hsu CY, Schieppati A. Chronic kidney disease and progression. NephSAP. 2006;5(3):156-160.
4. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144(1):21-28.
5. Reynolds K, Gu D, Muntner P, et al. Body mass index and risk of ESRD in China. Am J Kidney Dis. 2007;50(5):754-764.
6. Hsu CY, Go AS, McCulloch CE, Darbinian J, Iribarren C. Exploring secular trends in the likelihood of receiving treatment for end-stage renal disease. Clin J Am Soc Nephrol. 2007;2(1):81-88.
7. Schlessinger SD, Tankersley MR, Curtis JJ. Clinical documentation of end-stage renal disease due to hypertension. Am J Kidney Dis. 1994;23(5):655-660.
8. Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003;289(24):3273-3277.
9. Iseki K, Wakugami K, Maehara A, Tozawa M, Muratani H, Fukiyama K. Evidence for high incidence of end-stage renal disease in patients after stroke and acute myocardial infarction at age 60 or younger. Am J Kidney Dis. 2001;38(6):1235-1239.
10. Perry HM Jr, Miller JP, Fornoff JR, et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension. 1995;25(4, pt1):587-594.
11. Mohanram A, Zhang Z, Shahinfar S, Keane WF, Brenner BM, Toto RD. Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int. 2004;66(3):1131-1138.
12. Ishani A, Grandits GA, Grimm RH, et al. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol. 2006;17(5):1444-1452.
13. Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002;13(12):2888-2897.
14. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis. 2004;44(4):642-650.
15. Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis. 2006;47(1):51-59.
16. Fukuda M, Motokawa M, Miyagi S, et al. Polynocturia in chronic kidney disease is related to natriuresis rather than to water diuresis. Nephrol Dial Transplant. 2006;21(8):2172-2177.
17. Hebert LA, Greene T, Levey A, Falkenhain ME, Klahr S. High urine volume and low urine osmolality are risk factors for faster progression of renal disease. Am J Kidney Dis. 2003;41(5):962-971.
18. Wenzel UO, Hebert LA, Stahl RA, Krenz I. My doctor said I should drink a lot! recommendations for fluid intake in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2006;1(2):344-346.
19. Freedman BI, Soucie JM, McClellan WM. Family history of end-stage renal disease among incident dialysis patients. J Am Soc Nephrol. 1997;8(12):1942-1945.
20. Langefeld CD, Beck SR, Bowden DW, Rich SS, Wagenknecht LE, Freedman BI. Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis. 2004;43(5):796-800.
21. National Kidney Foundation. Kidney Early Evaluation Program: KEEP Annual Data Report 2006. Am J Kidney Dis. 2007;49(3)(suppl 3):S1-S160.
22. US Renal Data System 2007 annual data report. http://www.usrds.org/2007/ pdf/02-incid-prev-07.pdf. Accessed April 1, 2008.
23. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334(1):13-18.
24. Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT: Multiple Risk Factor Intervention Trial. JAMA. 1997;278(23):2069-2074.
25. Iseki K, Ikemiya Y, Fukiyama K. Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int. 1997;51(3):850-854.
26. Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63(4):1468-1474.
27. Halbesma N, Kuiken DS, Brantsma AH, et al. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol. 2006;17(9):2582-2590.
28. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men: 16-year MRFIT findings. JAMA. 1997;277(16):1293-1298.
29. Fored CM, Ejerblad E, Fryzek JP, et al. Socio-economic status and chronic renal failure: a population-based case-control study in Sweden. Nephrol Dial Transplant. 2003;18(1):82-88.
30. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med. 2005;165(8):923-928.
31. Gansevoort RT, Bakker SJ, de Jong PE. Early detection of progressive chronic kidney disease: is it feasible? J Am Soc Nephrol. 2006;17(5):1218-1220.
32. Taal MW, Brenner BM. Predicting initiation and progression of chronic kidney disease: developing renal risk scores. Kidney Int. 2006;70(10):1694-1705.
33. Karpinski M, Knoll G, Cohn A, Yang R, Garg A, Storsley L. The impact of accepting living kidney donors with mild hypertension or proteinuria on transplantation rates. Am J Kidney Dis. 2006;47(2):317-323.
34. Boudville N, Prasad GV, Knoll G, et al; Donor Nephrectomy Outcomes Research (DONOR) Network. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med. 2006;145(3):185-196.
35. Garg AX, Muirhead N, Knoll G, et al; Donor Nephrectomy Outcomes Research (DONOR) Network. Proteinuria and reduced kidney function in living kidney donors: a systematic review, meta-analysis, and meta-regression. Kidney Int. 2006;70(10):1801-1810.
36. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305.
37. Erlinger TP, Tarver-Carr ME, Powe NR, et al. Leukocytosis, hypoalbuminemia, and the risk for chronic kidney disease in US adults. Am J Kidney Dis. 2003;42(2):256-263.
38. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J. Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington county, Maryland. J Am Soc Nephrol. 2003;14(11):2934-2941.
39. Reynolds K, Gu D, Munter P, et al. A population-based prospective study of blood pressure and risk for end-stage renal disease in China. J Am Soc Nephrol. 2007;18(6):1928-1935.